Raymond James & Associates’s Vir Biotechnology VIR Stock Holding History

Raymond James & Associates’s Portfolio VIR Stock Details VIR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell
2024 Q2	$660K	Buy
2021 Q2	–	Sell
2021 Q1	$204K	Sell
2020 Q4	$470K	Buy
2020 Q3	$460K	Buy
2020 Q2	$541K	Buy